We offer a broad range of in-vitro test methods that are used for pre-clinical testing of active pharmaceutical ingredients and for assessing the cytotoxic and genotoxic potentials of environmentally and occupationally relevant substances. This also includes alternative test methods in line with the current European chemicals policy (REACH). Selection of the appropriate cellular test systems and development of the study design is performed in consultation with the sponsor, governed by a variety of criteria such as relevance of the species, organ, and target site, endpoints to be analyzed, compliance with the relevant guidelines (e.g. OECD), and any additional requirements.
Contact Press / Media
Dr. Tanja Hansen
Manager of the Working Group on In-vitro Test Systems
Phone +49 511 5350-226